Literature DB >> 15514923

RNA binding motif (RBM) proteins: a novel family of apoptosis modulators?

Leslie C Sutherland1, Nina D Rintala-Maki, Ryan D White, Cory D Morin.   

Abstract

RBM5 is a known modulator of apoptosis, an RNA binding protein, and a putative tumor suppressor. Originally identified as LUCA-15, and subsequently as H37, it was designated "RBM" (for RNA Binding Motif) due to the presence of two RRM (RNA Recognition Motif) domains within the protein coding sequence. Recently, a number of proteins have been attributed with this same RBM designation, based on the presence of one or more RRM consensus sequences. One such protein, RBM3, was also recently found to have apoptotic modulatory capabilities. The high sequence homology at the amino acid level between RBM5, RBM6, and particularly, RBM10 suggests that they, too, may play an important role in regulating apoptosis. It is the intent of this article to ammalgamate the data on the ten originally identified RBM proteins in order to question the existence of a novel family of RNA binding apoptosis regulators. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15514923     DOI: 10.1002/jcb.20204

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  68 in total

1.  Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate.

Authors:  Jennifer J Johnston; Jamie K Teer; Praveen F Cherukuri; Nancy F Hansen; Stacie K Loftus; Karen Chong; James C Mullikin; Leslie G Biesecker
Journal:  Am J Hum Genet       Date:  2010-05-06       Impact factor: 11.025

2.  Subnuclear targeting of the RNA-binding motif protein RBM6 to splicing speckles and nascent transcripts.

Authors:  Emma Heath; Fred Sablitzky; Garry T Morgan
Journal:  Chromosome Res       Date:  2010-11-18       Impact factor: 5.239

3.  Differential downregulation of Rbm5 and Rbm10 during skeletal and cardiac differentiation.

Authors:  Julie J Loiselle; Leslie C Sutherland
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-11-01       Impact factor: 2.416

4.  The nuclear splicing factor RNA binding motif 5 promotes caspase activation in human neuronal cells, and increases after traumatic brain injury in mice.

Authors:  Travis C Jackson; Lina Du; Keri Janesko-Feldman; Vincent A Vagni; Cameron Dezfulian; Samuel M Poloyac; Edwin K Jackson; Robert S B Clark; Patrick M Kochanek
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-31       Impact factor: 6.200

5.  FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.

Authors:  L Sehgal; R Mathur; F K Braun; J F Wise; Z Berkova; S Neelapu; L W Kwak; F Samaniego
Journal:  Leukemia       Date:  2014-04-03       Impact factor: 11.528

6.  Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas.

Authors:  Ivan Martinez; Jun Wang; Kenosha F Hobson; Robert L Ferris; Saleem A Khan
Journal:  Eur J Cancer       Date:  2006-10-31       Impact factor: 9.162

7.  Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection.

Authors:  Anyu Zhou; Alexander C Ou; Aeri Cho; Edward J Benz; Shu-Ching Huang
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

8.  Aberrant RNA Splicing in Cancer.

Authors:  Luisa Escobar-Hoyos; Katherine Knorr; Omar Abdel-Wahab
Journal:  Annu Rev Cancer Biol       Date:  2018-11-28

9.  Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer.

Authors:  Asa Ehlén; Donal J Brennan; Björn Nodin; Darran P O'Connor; Jakob Eberhard; Maria Alvarado-Kristensson; Ian B Jeffrey; Jonas Manjer; Jenny Brändstedt; Mathias Uhlén; Fredrik Pontén; Karin Jirström
Journal:  J Transl Med       Date:  2010-08-20       Impact factor: 5.531

10.  Down-regulating cold shock protein genes impairs cancer cell survival and enhances chemosensitivity.

Authors:  Yu Zeng; Prakash Kulkarni; Takahiro Inoue; Robert H Getzenberg
Journal:  J Cell Biochem       Date:  2009-05-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.